Thomas Gabrielczyk

Thomas Gabrielczyk's articles

GEA to open food biotech pilot-scale facility in USA
  1. Biotechnology

GEA to open food biotech pilot-scale facility in USA

Similar to GEA’s initial scaling facility for cell-based food production in Germany, the recently opened 10,000-square-metre facility in Janesville, Wisconsin is intended to assist scientists and entrepreneurs in the developing food technology sector to increase their production to industrial levels. With a 40% market share and a thriving start-up scene, the US is ahead of […]
Written by
EU set to improve investment for biotech start-ups and scale-ups
  1. Biotechnology

EU set to improve investment for biotech start-ups and scale-ups

The European Commission has unveiled a new strategy entitled ‘Choose Europe to start and scale’, which aims to strengthen the development and financing of start-ups and scale-ups within the European Union, particularly in innovation-driven sectors such as biotechnology, quantum computing and deep tech. The strategy, published on 28 May 2025, addresses the challenges faced by […]
Written by
Countdown to SLAS Europe: NestEgg Labs BV
  1. Biotechnology

Countdown to SLAS Europe: NestEgg Labs BV

Founded in 2022 by Tanner Carden (CEO) and Hans Keijdener, Maastricht-based start-up NestEgg Labs BV focuses on developing interoperable automation systems for cell culture that reduce manual intervention, improve workflow reproducibility, and limit plastics waste. At the core of NestEgg’s offering is Ovation, a smart incubator platform designed to automate key stages of the cell […]
Written by
Countdown to SLAS Europe: Minos Biosciences SAS
  1. Biotechnology

Countdown to SLAS Europe: Minos Biosciences SAS

Paris-based Minos Biosciences SAS’ (www.minos.bio) mission is to improve the understanding and treatment of complex diseases such as cancer, infectious and autoimmune diseases. As AI-powered drug discovery and therapeutic innovation holds great promise, the company’s MinoSuiteTM integrated cell analysis platform creates unprecedented multimodal datasets that will offer direct, ground-truth labels for AI training, opening  up […]
Written by
US President depriorises biotechnology - European Biotechnology Magazine
  1. Biotechnology

US President depriorises biotechnology – European Biotechnology Magazine

The order was published and executed to advance engineering biotechnology and biomanufacturing towards innovative solutions in health, climate change, energy, food security, agriculture, supply chain resilience, and national and economic security. President Trump’s U-turn on biotechnology could soon turn out to be an own goal. The Republican senators from five federal states – Nebraska, Indiana, […]
Written by
BRAIN Biotech partners with PX Group in microbial gold recycling
  1. Biotechnology

BRAIN Biotech partners with PX Group in microbial gold recycling

Industrial biotech specialist BRAIN Biotech and PX Group have extended its collaboration in highly effective microbial gold recovery from e-waste. Back in 2017, BRAIN Biotech developed a container-based mobile pilot plant for the bioleaching of metals dubbed BioXtractor. An advanced version called BioXtractor V2 was financed by PX Group and is now jointly owned by […]
Written by
SLAS: automation start ups set to enable P4 medicine
  1. Biotechnology

SLAS: automation start ups set to enable P4 medicine

Leroy Hood’s vision of P4 or ‘systemic’ medicine (preventive, predictive, personalised, participatory) is becoming a reality. By using omics data and medical records to create AI-powered individual health profiles, new automated product innovations aim to target diseases before symptoms even appear, reducing healthcare costs. On the second day of the SLAS 2025 conference, SLAS Ignite […]
Written by
Elevation Oncology Inc licences Synaffix BV's ADC platform
  1. Biotechnology

Elevation Oncology Inc licences Synaffix BV’s ADC platform

With the US$368m licence deal, Elevation Oncology, Inc is recognising Synaffix’s expertise in ADC development for the development of EO-1022. In contrast to Synaffix’s November deal with the Chinese BigHat Bioscience Co. Ltd, the US company does not book Lonza’s ADC manufacturing services that offers the same quality assurance process for all (clinicla) development phases, […]
Written by
Tetraspecific B/NK cell better than T cell engagers
  1. Biotechnology

Tetraspecific B/NK cell better than T cell engagers

The therapeutic landscape for relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL) is evolving toward targeted T-cell based immunotherapies, including CD19-targeted CAR-T and CD3xCD20 T-cell engaging (TCE) bispecificantibodies. Yet, there remains an unmet medical need for patients who are refractory to, or ineligible for these treatments. Leveraging natural killer NK cells emerges as a promising […]
Written by
Sphingotec secures Series C financing
  1. Biotechnology

Sphingotec secures Series C financing

Diagnostics company SphingoTec GmbH (Hennigsdorf, Germany) has successful closed a €5m Series C financing round led by Think.Health Ventures, with support from existing investors Brandenburg Kapital, HBM Healthcare Investments, NRW.BANK, and Wellington Partners. The raised capital will allow the company to reach profitability through partnerships and licence deals of its kidney function test penKid and […]
Written by
Gourmey files first EU application for cell-based meat
  1. Biotechnology

Gourmey files first EU application for cell-based meat

At the time of its EU market authorisation application, Gourmey SAS, which has raised €57.8m so far, has applied for authorisation from the competent authorities in the UK, Switzerland, Singapore and the USA. Ivo Rzegotta, responsible for political communication at GFI Europe interest group, described the application as an important signal for the sector: ‘Cultivated […]
Written by

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.